Cite
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial.
MLA
Bosch-Nicolau, Pau, et al. “Efficacy of Three Benznidazole Dosing Strategies for Adults Living with Chronic Chagas Disease (MULTIBENZ): An International, Randomised, Double-Blind, Phase 2b Trial.” Lancet Infectious Diseases, vol. 24, no. 4, Apr. 2024, pp. 386–94. EBSCOhost, https://doi.org/10.1016/S1473-3099(23)00629-1.
APA
Bosch-Nicolau, P., Fernández, M. L., Sulleiro, E., Villar, J. C., Perez-Molina, J. A., Correa-Oliveira, R., Sosa-Estani, S., Sánchez-Montalvá, A., del Carmen Bangher, M., Moreira, O. C., Salvador, F., Mota Ferreira, A., Eloi-Santos, S. M., Serre-Delcor, N., Ramírez, J. C., Silgado, A., Oliveira, I., Martín, O., Aznar, M. L., & Ribeiro, A. L. P. (2024). Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial. Lancet Infectious Diseases, 24(4), 386–394. https://doi.org/10.1016/S1473-3099(23)00629-1
Chicago
Bosch-Nicolau, Pau, Marisa L Fernández, Elena Sulleiro, Juan Carlos Villar, José A Perez-Molina, Rodrigo Correa-Oliveira, Sergio Sosa-Estani, et al. 2024. “Efficacy of Three Benznidazole Dosing Strategies for Adults Living with Chronic Chagas Disease (MULTIBENZ): An International, Randomised, Double-Blind, Phase 2b Trial.” Lancet Infectious Diseases 24 (4): 386–94. doi:10.1016/S1473-3099(23)00629-1.